Combined sulforaphane and β-sitosterol mitigate olanzapine-induced metabolic disorders in rats: Insights on FOXO, PI3K/AKT, JAK/STAT3, and MAPK signaling pathways
-
Published:2024-10
Issue:
Volume:140
Page:112904
-
ISSN:1567-5769
-
Container-title:International Immunopharmacology
-
language:en
-
Short-container-title:International Immunopharmacology
Author:
El-Shoura Ehab A.M.,
Abdelzaher Lobna A.,
Mahmoud Nesreen I.,
Farghaly Omar A.,
Sabry Mostafa,
Girgis Shahataa Mary,
Salem Esraa A.,
Saad Hebatallah M.ORCID,
Elhussieny Omnya,
Kozman Magy R.,
Atwa Ahmed M.ORCID